Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Completed · Phase 2
Conditions studied: Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus donor bone marrow transplantation in treating patients who have hematologic cancer.
Key facts
- Study ID
- NCT00003960
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- People needed
- 36
- Starts
- 1998-04-01
- Expected to finish
- 2001-09-01
- Last updated by the study team
- 2014-05-02
Who can join
Age: 19 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Johns Hopkins Oncology Center — Baltimore, Maryland, United States
- Center for Cancer Treatment and Research — Columbia, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.